This news is delayed by 15 minutes, sign up now to get live news & full features.
MLYS MINERALYS THERAPEUTICS INC
+ add to watchlist
$34.98
at mineralys therapeutics we aim to redefine hypertension diagnosis, management and treatment. we are driven to break the “trial and failure” approach to hypertension management and bring a personalized approach to the management of hypertension.
Mkt Cap: $2.31B
52 Week High: $35.09
P/E: 0.00
52 Week Low: $8.24
Dividend: $0.00
Shares Outstanding: 66.3M